Mack CL, Miethke AG, Hawthorne K, Henn L, Horslen S, Alonso EM, Gupta NA, Sundaram SS, Kohli R, Bozic M, Deneau M, Guthery S, Loomes KM, Valentino PL, Tessier MEM, Shneider B, Magee JC, Karpen S, Rosenthal P, Wang K, Ricciuto A, Sokol RJ, Kamath BM. The Childhood Liver Disease Research Network's prospective characterization of pediatric primary sclerosing cholangitis. Hepatol Commun. 2026 Oct 01; 10(10).

Valença-Pereira F, Johnson B, DeGregori J, Rincon M. Does acute inflammation triggered by infection promote cancer progression? PLoS Biol. 2026 Sep; 24(9):e3003962.

Mikeska RG, Feldman LER, Woodruff ER, Iwanaga R, Linder KE, Yamamoto TM, Sompel K, Jordan KR, Post MD, Zoller M, Bitler BG, Marjon NA. Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma. Cancer Res Commun. 2026 Sep 01; 6(9):2256-2270.

Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2026 Sep; 27(9):1094-1109.

Paganoni S, Chibnik LB, Quintana M, Macklin EA, Detry MA, Vestrucci M, Paulon G, McGlothlin A, Wang J, Walk D, Elman L, Chase M, Heyd L, Harkey B, Sherman AV, Shefner J, Berry JD, Scirocco E, Giacomelli E, Yu H, Kittle G, Hall M, Ho D, Jawdat O, Ladha S, Locatelli E, Rivner M, Felice K, Katz J, Ajroud-Driss S, Fee D, Miller T, Rosow L, Quick A, Heitzman D, Foster LA, Maragakis NJ, Goutman SA, Rosenfeld J, Benatar M, Swenson A, Connors RD, Shroff S, Bedlack R, McIlduff CE, Chen IA, Fernandes JAM, Walsh A, Peltier A, Ilieva H, Diaz F, Kushlaf H, Beydoun SR, Myers B, Arcila-Londono X, Heiman-Patterson T, Elliott M, Whitesell J, Al-Lahham T, Elliott M, Olney N, Baer M, Jackson C, Young E, Caress J, Weiss MD, Kuenzler R, Nayar S, Kasarskis EJ, Simmons Z, Gibson S, Owegi MA, Goyal NA, Wymer JP, Gwathmey KG, Erickson A, Gursoy N, Alameda G, Bodkin C, Wu A, Martinez-Thompson J, Twydell PT, Andrews J, Bayat E, Rezania K, Usman U, McCluskey L, Kovvuru S, Jennings D, Garza-Meilandt A, Maciuca R, Cohen IV, Tamuly D, Eren E, Cudkowicz ME, Babu S. DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2026 Sep 01; 9(9):e2634809.

Phung Khanh L, Rosenberger KD, Dong Thi Hoai T, Nguyen Tan Thanh K, Tran Van N, Nguyen Tran N, Do Chau V, Nguyen Van K, Yacoub S, Chanpheaktra N, Kumar V, Lum Chai See L, Sathar J, Sandoval EP, Marón GM, Laksanawati IS, Mahendradhata Y, Hassan MZ, Ahmed F, Caprara A, Benevides BS, Marques ETA, Magalhaes T, Brasil P, Netto M, Tami A, Bethencourt SE, Guzman MG, Simmons C, Nguyen Than Ha Q, Wolbers M, Geskus RB, Jaenisch T, Wills B. Improving early prediction for adverse dengue outcomes using data from the IDAMS prospective multicentre study. Nat Commun. 2026 Aug 21; 17(1).

Zohaib Ali M, Dutt TS, Patterson J, Minic A, Jordan KR, Maloney Norcross SE, Meibohm B, Gonzalez-Juarrero M. Spatial and temporal immune landscapes of non-necrotic granulomas in two murine tuberculosis models with divergent disease outcomes. Front Immunol. 2026; 17:1821629.

Ziogas IA, Conover KR, Dobrinskikh E, Al-Juboori SI, Gromer KD, Malladi P, Wright CJ, Sokol RJ, Andrews T, Taylor SA. Spatial transcriptomics supports a role for SOX4-driven signaling throughout the disease course of biliary atresia. Hepatol Commun. 2026 Aug 01; 10(8).

Xi Y, Thorand B, Schneider A, Wolf K, Dallavalle M, Nikolaou N, Linkohr B, Kronenberg F, Rathmann W, Schlesinger S, Herder C, Schwettmann L, Zeller T, Jumpertz von Schwartzenberg R, Breitner-Busch S, Peters A. Association of long-term exposure to air pollution, built environment and air temperature with the incidence of prediabetes phenotypes, and prediabetes remission and progression to type 2 diabetes: a longitudinal study in the KORA cohort. Diabetologia. 2026 Oct; 69(10):2819-2832.

Athinarayanan SJ, Bjornstad P, Shanmugam PV, Weimbs T, Wolfberg AJ, Volek JS, Himmelfarb J, Johnson RJ. Effectiveness of Telehealth Low-Carbohydrate Intervention in Preventing Chronic Kidney Disease: A Real-World, Retrospective, Matched Cohort Study. Diabetes Obes Metab. 2026 10; 28(10):9054-9068.